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Introduction
Staphylococcus aureus is a major cause of hospital-
and community-acquired infections, and can results in
serious consequences. Hospital infections caused by S.
aureus include those affecting the bloodstream, lower
respiratory tract, skin and soft tissues, as well as venti-
lator-assisted pneumonia and central venous catheter-
associated bacteraemia. The importance of S. aureus as
a human pathogen, apart from its ability to cause a
diverse range of life-threatening infections, is its
extraordinary potential to develop antimicrobial resist-
ance [7].
One of the class of antibiotics playing an important
role in the therapy of serious staphylococcal infections
are aminoglycosides despite reports of increased
resistance to these drug in many countries of the
Europe [11]. The main mechanism of aminoglycoside
resistance is drug inactivation by aminoglycoside-
modifying enzymes (AMEs) encoded within mobile
genetic elements [14]. The following three AMEs are
of particular significance among staphylococci since
they modify and thereby inactivate the traditional
aminoglycosides of therapeutic importance: aminogly-
coside-6'-N-acetyltransferase/2"-O-phosphoryltrans-
ferase [AAC(6')/APH(2")], aminoglycoside-4'-O-
nucleotidyltransferase I [ANT(4')-I] and aminoglyco-
side-3'-O- phosphoryltransferase III [APH(3')-III].
Resistance to gentamicin and concomitant resistance
to tobramycin and kanamycin in staphylococci are
mediated by bifunctional enzyme displaying AAC(6')
and APH(2") activity encoded by aac(6’)-Ie+aph(2”)
gene. Resistance to neomycin, kanamycin, tobramycin
and amikacin is mediated by an ANT(4')-I enzyme
encoded by ant(4’)-Ia gene. The APH(3')-III enzyme,
which inactivates kanamycin and neomycin is encod-
ed by aph(3’)-IIIa gene [12, 14]. Resistance to strepto-
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mycin in staphylococci is associated with the enzymes
ANT(6)-I and APH(6)-I encoded by ant(6)-Ia and str
genes, respectively [11,12,14].
As aminoglycosides resistance and the distribution
of the genes encoding aminoglycoside-modifying
enzymes has not been well characterized or document-
ed in large collection of  S. aureus in Poland, we inves-
tigated S. aureus strains isolated from a University
Hospital, in order to gain some insight into the nature
of the resistance to this class of antibiotics.
Materials and methods
Bacteria. A total of 118 S. aureus isolates obtained during 2002-06
at the University Hospital were included in this study. All isolates
were identified as S. aureus by ID 32 Staph (bioMerieux, France)
according to the manufacturer instructions. Pure culture were pre-
served in 30% glycerol at -80°C and were subcultured in brain
heart infusion broth, and incubated at 37°C prior to further testing.
Multiple isolates of the same patient were excluded. 
Antimicrobial agents and susceptibility testing. Antimicrobial
susceptibility testing was performed using disk diffusion method
on Mueller-Hinton agar plates. S. aureus ATCC 29213 was used as
quality control strain for in vitro susceptibility testing. The anti-
bacterial agents tested were: gentamicin (10 µg), amikacin (30 µg),
netilmicin (30 µg), tobramycin (10 µg), kanamycin (30 µg) and
neomycin (30 µg). Susceptibility to aminoglycosides was inter-
preted according to document M2-A8 of the Clinical and Labora-
tory Standards Institute (CLSI; formerly the National Committee
for Clinical Laboratory Standards , NCCLS) [9].   
PCR amplification of aminoglycosides resistance genes. All iso-
lates demonstrating resistance to at least one of the aminoglycoside
antibiotics were screened for the presence of the aac(6’)-
Ie/aph(2”), ant(4’)-Ia, aph(3’)-IIIa, ant(6)-Ia and str genes.
Genomic DNA as a template for PCR assay was extracted by incu-
bating with lysostaphin followed by purification with a commer-
cially available purification kit (Eurx, Poland). 
The aac(6’)-Ie/aph(2”), ant(4’)-Ia, aph(3’)-IIIa, ant(6)-Ia and
str genes were detected by previously described primers [2, 5, 11].
PCR was performed in a Perkin-Elmer DNA thermal cycler, for the
first of fourth genes at 94°C for 10 min, then 35 cycles at 94°C for
45 s, 60°C for 60 s, and 72°C for 60 s. A final extension cycle of
72°C for 5 min was applied. The following program was used for
amplification of fragment of str gene: denaturation at 94°C for 3
min, then 30 cycles of 94°C for 45 s, 55°C for 45 s, and 72°C for
60 s, and final extension at 72°C for 10 min.
The Gene Ruler 100 bp DNA Ladder Plus (MBI Fermentas,
Lithuania) was used as a molecular size marker on the gels. All iso-
lates were tested at least twice at independent occasions before
being considered as positive. 
Results
Of  total 118 S. aureus isolates included in this study,
45 (38.1%) were resistant to at least one of the tested
aminoglycoside antibiotics (Table 1). All isolates
except one (97.8%) were resistant to kanamycin. The
majority of strains 37 (82.2%) and 32 (71.1%)
expressed resistance to neomycin and tobramycin,
respectively. Eleven strains (24.4%) were resistant to
gentamicin or amikacin. The most active antimicrobial
agents against S. aureus was netilmicin. All isolates
were sensitive to this drug.
With regard to resistance phenotypes, only 3
(6.7%) isolates were resistant to the greatest number of
antibiotics tested, and were sensitive only to
netilmicin. The great number of S. aureus isolates 13
(28.9%) were resistant to tobramycin, kanamycin and
neomycin followed by resistance to kanamycin and
neomycin in 12 (26.7%) isolates. Resistance to
amikacin, tobramycin, kanamycin and neomycin was
observed in 7 (15.6%) isolates, and the same number
of strains were resistant to gentamicin, tobramicin and
kanamicin. The other three resistance phenotypes:
gentamicin/tobramycin/kanamycin/neomycin,
amikacin/kanamycin/neomycin or tobramycin were
observed in one (2.2%) isolate.  
All of aminoglycosides resistant S. aureus were
screened for the presence of three genes encoding the
most clinically relevant aminoglycoside modifying
enzymes (Table 1). The most prevalent resistance gene
was aac(6’)-Ie+aph(2’) found in 13 (28.9%) strains.
Twelve (26.7%) isolates carried  ant(4’)-Ia gene,
whilst aph(3’)-IIIa gene was detected in only 7
(15.6%) isolates.  Additionally, the ant(6)-Ia and str
genes were detected in 14 (31.1%) and 2 (4.4%)
strains, respectively. Ten (22.2%) strains resistant to
amikacin, tobramycin, kanamycin or neomycin did not
harbor any of the above-noted genes. 
Discussion
Aminoglycoside resistance is common in S. aureus
isolated from different countries, and especially gen-
tamicin resistance, is of clinical importance because it
can compromise the therapeutic effectiveness of these
antibacterial agents [15]. 
Since PCR is a reliable tool for the identification of
aminoglycoside modifying enzyme gene in staphylo-
cocci [5,11], it was used in this study to detect the
aac(6’)-Ie+aph(2’), ant(4’)-Ia, aph(3’)-IIIa, ant(6)-Ia
and str genes in the S. aureus tested, and, hence the
enzymes they encode. 
The incidence of ANT(4') in this study was higher
than that reported in other studies were the AAC(6')-
APH(2") enzyme has been found to be the most com-
mon AME in S. aureus [3,10,15]. The higher incidence
of the ANT(4') enzyme was because it included iso-
lates that were resistant to kanamycin, gentamicin sus-
ceptible and contained genes for only the ANT(4')
enzyme. The results were in agreement with results of
antibiotic resistance testing which demonstrated that
44 of the 45 isolates were kanamycin resistant, and
with results aminoglycoside resistance in S. aureus
isolated in Kuwait hospitals [13]. Similarly, the study
carried out in Japan reported much higher prevalence
of ANT(4') enzyme than that of the other two AME
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enzymes [6]. However, insignificant frequently was
detected genes for AAC(6')-APH(2") enzyme, which
is similar to other reports that studies S. aureus [4,8,
10,12,15,16]. Although, it have been demonstrated an
upward in the proportions of AAC(6')-APH(2") and
ANT(4') in aminoglycoside resistant S. aureus in our
study in comparison with other European hospitals
[11]. In contrast, netilmicin had excellent activity
against all isolates. Similarly, Vanhoof et al. [15]
reported a low incidence of netilmicin resistance
among S. aureus in Belgium hospitals. Because of its
activity against the all isolates, a combination of
netilmicin and tobramycin has been advocated for the
treatment of infections caused by aminoglycoside
resistant strains producing AAC(6')-APH(2") enzyme
since the combination acts synergistically [1].   
Streptomycin resistance is mainly associated with
ant(6)-Ia, str, or ant(3")-Ia genes [14]. Within the S.
aureus population under study, resistance to this
antibiotic was mainly encoded by ant(6)-Ia. Com-
parative analysis of our results is difficult due to
poorly data on resistance to streptomycin in S.
aureus.  
The strains harboring aac(6’)-Ie+aph(2’) gene
encoding AAC(6')-APH(2") enzyme are considered to
be resistant to gentamicin and even to all aminoglyco-
sides. However, in our study this gene was detected in
two gentamicin susceptible isolates. In some studies
have also reported similar findings [10, 13, 15]. The
detection of resistance genes in antibiotic susceptible
isolates may be due to the amplification of repressed
antibiotic resistance gene [10] or AME of these strains
display lower enzymatic activity, detected also in other
study of S. aureus [15].
It is noteworthy to mention that in the 10 isolates
demonstrating phenotypic resistance to any one of the
antibiotics tested, we did not detect a known gene
encoding an aminoglycoside modifying enzyme which
could account for the phenotype. Because it is possible
to deduce the type of enzyme present from the patterns
of resistance (resistance to amikacin, tobramycin,
kanamycin and neomycin, and susceptibility to gen-
tamicin), these strains pointed toward the presence of
the enzymes encoded by ant(4’)-Ia or aph(3’)-IIIa
genes. The failure to detect these two genes may be
due to either the presence of an ant(4’)-Ia or aph(3’)-
IIIa variant gene that cannot be detected with the
primers used or this suggests that new aminoglycoside
resistance genes are circulating within the S. aureus
population.  
DNA methods that detect resistance genes appear
to be very sensitive in detecting resistance mechanism
even when the resistance is not expressed. This is sig-
nificant because exposure of these organism to the
antibiotics at a later date will result in the expression
of full resistance if the genes are present, and can influ-
ence proper prescription, and use of appropriate agents
for therapy. 
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